Carmen Nițu, D. Ștefan *
* Dr. Carmen Nițu, Dr. Dan Ștefan – IPSEN Beaufour
Article information. Therapeutical Practice · Ther Pharmacol Clin Toxicol 1997;1(2):81 · Article in Romanian with an English abstract
Abstract
Forlax, developed by the Beaufour IPSEN Laboratories, belongs to a new class of osmotic laxative agents. Its active principle, macrogol 4000, increases the water content of the stools and therefore their volume; this facilitates peristaltis, improves the consistency of the feces which will ease their passage and their discharge. Clinical studies also confirmed the excellent tolerance of Forlax at the dosage of 1-2 sachets per day.
Cite as: Nițu C, Ștefan D. Forlax-noua clasă de laxative. Ther Pharmacol Clin Toxicol. 1997;1(2):81.